Proteomic analysis of cancer patient plasma samples · FederalPipeline
Proteomic analysis of cancer patient plasma samples
Combined Synopsis/Solicitation from Food and Drug Administration, solicitation 75F40125Q00169. Responses due Jun 20, 2025. NAICS 541720. Listed on SAM.gov.